| Theme | Liver Fibrosis : Beyond the Diagnosis | |
|---|---|---|
| Title | Recent Development and Future Prospects of Therapy Targeting Liver Fibrosis Regression and Liver Regeneration | |
| Publish Date | 2018/12 | |
| Author | Atsunori Tsuchiya | Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University |
| Author | Masahiro Ogawa | Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University |
| Author | Shunsuke Nojiri | Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University |
| Author | Takayuki Watanabe | Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University |
| Author | Suguru Takeuchi | Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University |
| Author | Shuji Terai | Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University |
| [ Summary ] | Previously, liver cirrhosis was thought to be irreversible. However, recently a great deal of evidence has indicated that liver cirrhosis is reversible after anti-viral therapy using direct acting antivirals for the hepatitis C virus and nucleotide analogue for the hepatitis B virus. Furthermore basic studies and clinical studies targeting regression of fibrosis are ongoing. In this section, we will introduce the recent basic and clinical study targeting fibrogenesis and fibrolysis. | |